Commentary
California
California Doubles Down on Unworkable Data Privacy Law During Second COVID Shutdown
Businesses were ordered to close. Schools were shuttered. People were told to stay home. Many believed that in a week or two life for the most part would return to normal and that COVID would be a bad memory. Now, four months later, California has not just halted reopening but ...
Commentary
Why Trump administration should say goodbye to ‘Buy America’
It’s not often that Joe Biden agrees with President Trump. But the former vice president found common ground with his presumptive opponent this month when he announced he would outline a plan to bring medical manufacturing back to the United States, something the president has long endorsed. This isn’t the ...
Commentary
COVID-19’s Long-Term Effects Raise the Stakes of the Game.
Despite the surge of new cases of COVID-19, increases in the percentage of positive tests, and scores of ICUs at or near capacity, some commentators are still saying things like, “The so-called surge in cases is more fake news pushed by media cheerleaders eager to destroy the U.S. economy and culture ...
Commentary
Executive Order On Drug Price Controls Would Backfire
Rumor has it that President Trump will soon issue a sweeping executive order to lower prescription drug prices by fiat. Nothing is set in stone. But the order would reportedly index the government’s reimbursements for medicines to the prices that Britain, France, Canada, and other developed nations pay. Since all those nations ...
Commentary
Covid’s Harrowing Complications
It’s good news that the death rate from Covid-19 has trended dramatically downward since April, even as the number of new cases is surging. But it’s far from the whole story. Unlike common colds caused by other coronaviruses, Covid-19 is more than a transient, self-limited respiratory infection. There have been ...
Commentary
Patients Will Suffer The Most From The Trump Administration’s Reference Pricing Scheme
The pharmaceutical industry has responded to the Covid-19 pandemic with, arguably, the greatest surge in drug innovation in history. Consider that Remdesivir (produced by Gilead) has already received an emergency use authorization by the FDA for Covid-19. Losmapimod (produced by Fulcrum) is another promising treatment for Covid-19 that is in Phase III trials. And, ...
Commentary
Biden a moderate? Sanders, AOC plans for candidate suggest this instead
Presumptive Democratic presidential nominee Joe Biden has long been considered a political moderate. A new report from his “unity” task forces should put that reputation to rest. The 110-page document offers detailed policy recommendations for an incoming Biden administration. It would represent the most left-wing governing program of any president ...
Commentary
Medicaid Expansion Will Add To Oklahoma’s Woes
Late last month, Oklahoma voters narrowly approved a ballot measure expanding the state’s Medicaid program to childless adults making up to 138% of the poverty level under the terms of Obamacare. Missouri could follow suit next month when a similar ballot initiative comes up for a vote. Medicaid expansion seems ...
California
Racial preferences or school choice? How to improve education for non-white students
One of the most important questions in America today is how to improve the quality of education for underrepresented minorities so that they can succeed in life. Two huge political earthquakes offer two vastly different answers: racial preferences and school choice. In the first earthquake, the California Legislature voted to ...
Blackouts
State Move Toward All-Electric Buildings Would Be Another Hit to California’s Working Class
At roughly the same time the state Air Resources Board issued a rule forcing trucks and vans to transition from diesel to electric motors, the state moved closer to a policy framework in which new buildings must be all-electric. The smiling environmental lobby feels no mercy toward the poor, who ...
California Doubles Down on Unworkable Data Privacy Law During Second COVID Shutdown
Businesses were ordered to close. Schools were shuttered. People were told to stay home. Many believed that in a week or two life for the most part would return to normal and that COVID would be a bad memory. Now, four months later, California has not just halted reopening but ...
Why Trump administration should say goodbye to ‘Buy America’
It’s not often that Joe Biden agrees with President Trump. But the former vice president found common ground with his presumptive opponent this month when he announced he would outline a plan to bring medical manufacturing back to the United States, something the president has long endorsed. This isn’t the ...
COVID-19’s Long-Term Effects Raise the Stakes of the Game.
Despite the surge of new cases of COVID-19, increases in the percentage of positive tests, and scores of ICUs at or near capacity, some commentators are still saying things like, “The so-called surge in cases is more fake news pushed by media cheerleaders eager to destroy the U.S. economy and culture ...
Executive Order On Drug Price Controls Would Backfire
Rumor has it that President Trump will soon issue a sweeping executive order to lower prescription drug prices by fiat. Nothing is set in stone. But the order would reportedly index the government’s reimbursements for medicines to the prices that Britain, France, Canada, and other developed nations pay. Since all those nations ...
Covid’s Harrowing Complications
It’s good news that the death rate from Covid-19 has trended dramatically downward since April, even as the number of new cases is surging. But it’s far from the whole story. Unlike common colds caused by other coronaviruses, Covid-19 is more than a transient, self-limited respiratory infection. There have been ...
Patients Will Suffer The Most From The Trump Administration’s Reference Pricing Scheme
The pharmaceutical industry has responded to the Covid-19 pandemic with, arguably, the greatest surge in drug innovation in history. Consider that Remdesivir (produced by Gilead) has already received an emergency use authorization by the FDA for Covid-19. Losmapimod (produced by Fulcrum) is another promising treatment for Covid-19 that is in Phase III trials. And, ...
Biden a moderate? Sanders, AOC plans for candidate suggest this instead
Presumptive Democratic presidential nominee Joe Biden has long been considered a political moderate. A new report from his “unity” task forces should put that reputation to rest. The 110-page document offers detailed policy recommendations for an incoming Biden administration. It would represent the most left-wing governing program of any president ...
Medicaid Expansion Will Add To Oklahoma’s Woes
Late last month, Oklahoma voters narrowly approved a ballot measure expanding the state’s Medicaid program to childless adults making up to 138% of the poverty level under the terms of Obamacare. Missouri could follow suit next month when a similar ballot initiative comes up for a vote. Medicaid expansion seems ...
Racial preferences or school choice? How to improve education for non-white students
One of the most important questions in America today is how to improve the quality of education for underrepresented minorities so that they can succeed in life. Two huge political earthquakes offer two vastly different answers: racial preferences and school choice. In the first earthquake, the California Legislature voted to ...
State Move Toward All-Electric Buildings Would Be Another Hit to California’s Working Class
At roughly the same time the state Air Resources Board issued a rule forcing trucks and vans to transition from diesel to electric motors, the state moved closer to a policy framework in which new buildings must be all-electric. The smiling environmental lobby feels no mercy toward the poor, who ...
